Launch target lists
Build ranked HCP and account universes for new therapies, devices, or service lines. Filter by specialty, geography, signals, and fit.
RxGTM turns public and licensed healthcare data into provider, KOL, and account maps that commercial teams can trust, explain, and export.
Use RxGTM when the market is specific, the field motion matters, and the team needs evidence-backed lists faster than a custom data project.
Build ranked HCP and account universes for new therapies, devices, or service lines. Filter by specialty, geography, signals, and fit.
Identify providers and sites with trial involvement, academic influence, relevant relationships, and clear reason codes.
Prioritize specialists, practices, and regions using procedure proxies, account signals, and underpenetrated territory views.
Match, dedupe, enrich, and export provider records with NPI, specialty, location, evidence fields, confidence, and source freshness.
Surface relevant manufacturer relationships and market activity without asking teams to manually search payments, trials, and provider registries.
Give RxGTM one indication, device category, or target geography. Get a transparent, exportable map your team can review and act on.
RxGTM is not another static database. It is an execution layer between healthcare data sources, market hypotheses, and commercial action.
Start with a therapy area, procedure category, indication, geography, specialty, seed list, or CRM export.
Match providers, sites, organizations, and source records into a clean healthcare identity spine.
Rank opportunities using source-backed signals, confidence scores, and explainable reason codes.
Deliver CSVs, account briefs, provider profiles, and CRM-ready fields for launch, field, or medical teams.
Start with public healthcare data. Add licensed contact, claims, or CRM data when the use case justifies it.
RxGTM is designed for teams that need speed, but cannot accept black-box targeting logic or unsupported outreach claims.
The clearest path is not a platform demo. It is one market, one workflow, and one evidence-backed output your team can judge.